Galapagos | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
argenx SE USD 286.9M 84.54M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Biogen USD 744M 432.8M 2025-06
Genmab DKK 244M 3.36B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 1.89B 221M 2025-06
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Incyte USD 558.01M 323.82M 2025-06
Merck EUR 956M 147M 2025-03
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
UCB EUR 1.22B 781M 2024-12
Vertex Pharmaceuticals USD 730.4M 585.6M 2025-03


Galapagos L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.